Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
about
Economic Evaluations of Childhood Influenza VaccinationInfluenza vaccines for preventing cardiovascular diseaseInfluenza vaccines for preventing coronary heart diseaseSeasonal inactivated influenza virus vaccinesT-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective VaccinesInfluenza vaccination in the elderly: why are the overall benefits still hotly debated?Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic reviewInfection prevention and the medical director: uncharted territoryAging, diabetes, and the public health system in the United StatesFluad®-MF59®-Adjuvanted Influenza Vaccine in Older AdultsThe unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignMutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonucleaseEstimating the secondary attack rate and serial interval of influenza-like illnesses using social mediaInfluenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for biasOptimal pandemic influenza vaccine allocation strategies for the Canadian populationSocial determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative dataImpact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults.The pandemic influenza A (H1N1) 2009 vaccine does not increase the mortality rate of idiopathic interstitial pneumonia: a matched case-control study.Seasonal influenza vaccination and technologies.Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in SingaporeInfluenza vaccines to control influenza-associated bacterial infection: where do we stand?Influenza vaccination coverage among adults in Korea: 2008-2009 to 2011-2012 seasons.Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Influenza surveillance and immunisation in New Zealand, 1997-2006.Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.Optimal pandemic influenza vaccine allocation strategies for the canadian population.Seasonal influenza vaccination of high-risk adults.Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus?Influenza vaccination of healthcare workers, oseltamivir resistance and prepandemic vaccination.Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to InfluenzaInfluenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.Pandemic and seasonal vaccine coverage and effectiveness during the 2009-2010 pandemic influenza in an Italian adult population.Vaccine allocation in a declining epidemic.
P2860
Q22305810-AD60D13D-A307-4F72-ADB9-9E5EB834E456Q24188037-5D5CCC4C-F364-4F3A-835E-81379AE844D5Q24242669-A89B8BC0-9A88-4D54-A6FD-58694F3E9A6AQ24652665-1E200F03-2CAE-4C2F-8EC6-ED85B1C958EEQ26768539-E475FB6B-A2D1-4542-A26B-943C56A9AF76Q26770659-567E7B44-AAB7-402F-B016-1BD6D9940AEDQ26782188-1551811F-7CD2-4EB0-AD4C-5215C7C5C65CQ26825010-9EE878E7-9495-40B5-865E-2EEC531C6781Q26852929-A404BC46-CA29-4F54-ADA4-67E1E9B1F159Q27009478-23A922DB-7224-415C-8630-C8D52C4E4CD9Q27025076-BA38ED06-90D0-4FD0-BF70-F19CCBDAF57BQ28071809-50DA2BEF-927D-413A-AA8E-709D61D07125Q28534627-A06AF0BD-F8FA-4D37-9DBA-86336267D0E7Q28648159-2A075436-1297-4CAC-AB03-E5CAC1056BA7Q28742116-C2C6FF2B-BE95-4B02-A6D8-E81D57F353CAQ28752312-51E10C48-FD52-4FEE-8462-75F8291296DBQ30000798-915E5E5A-B05E-400A-B4A9-D591B4314DEDQ30352081-383A5808-A96A-4DD2-8803-D490650C221CQ30359671-8D1534B2-6593-475F-BCA8-9C98D9593E64Q30360897-4502B695-187E-4516-A7B8-7F183B9AF80FQ30365168-751E6E09-FE3B-4544-A4A1-B36B3CEEA456Q30366650-54D3AF8F-192D-46C0-97F1-19ACC5DC4B37Q30368980-411E612D-33CC-4592-AA65-67DFAE96EEE7Q30373099-C77E3859-4D20-48BB-B515-A4F87D3A3496Q30377231-D3049F94-D237-4ED3-A52E-651C4BB4A356Q30377295-9FCAAB01-342A-45CA-9581-4280339F7170Q30383318-66D48108-010B-45EF-8952-D304795783C8Q30384318-43743C38-1798-4FBA-BAB2-79D50C9367FFQ30387979-7427187A-C8CE-4F97-AA35-9EA7D3C867C9Q30388008-0EB3E7BE-FDEC-49C3-B7A0-D3568CD5E58EQ30389269-92B28296-8881-4C25-A989-AFF80847E86DQ30389700-78FE2043-1682-448F-992A-D3CFAB1CDEF0Q30397977-7642D891-5498-4392-AA4E-06C692AA8C73Q30403117-7EB95BE9-23DC-405A-9E2D-53AFE672AA36Q30404989-5BB14BA1-A912-4238-A575-062C9DE66BABQ30405145-8D971509-EFAA-4500-8277-2915996D46C0Q30407593-05CE7B7E-7533-418D-8574-DE5A7D42BE49Q30412266-B736E322-7CAD-437D-97CB-3A2065DCBE79Q30413569-4CD708F2-0592-46EB-A19F-FAAB4683A459Q30418929-1BC025A1-D958-43A3-8106-BA49A009FD92
P2860
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@ast
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@en
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@nl
type
label
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@ast
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@en
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@nl
prefLabel
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@ast
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@en
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@nl
P50
P1476
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.
@en
P2093
Lisa A Jackson
Robert J Taylor
P304
P356
10.1016/S1473-3099(07)70236-0
P407
P577
2007-10-01T00:00:00Z